Ultragenyx's Strong Pipeline And Valuation Concerns: A Balanced Perspective (NASDAQ:RARE)
By Press Room
6 Mins read
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) develops innovative therapies for rare and ultra-rare genetic diseases. Its commercial portfolio includes Crysvita, Mepsevii, Dojolvi, and Evkeeza,…
Oracle (NYSE:ORCL) is another beneficiary of the recent AI boom, as its stock performance over the past year can attest. ORCL 5Y…
Navios Maritime Partners L.P. Common Units (NMM) Q2 2024 Earnings Call Transcript
By Press Room
17 Mins read
Navios Maritime Partners L.P. Common Units (NYSE:NMM) Q2 2024 Earnings Conference Call August 20, 2024 8:30 AM ET Company Participants Angeliki Frangou…
Editor’s note: Seeking Alpha is proud to welcome Bryant Trombly as a new contributing analyst. You can become one too! Share your…
Introduction Last week, Shopify (NYSE:SHOP) (TSX:SHOP:CA) announced its Q2 2024 results and the market reacted very enthusiastically and the stock shot up…
I wasn’t thrilled with First Hawaiian’s (NASDAQ:FHB) immediate prospects when I last covered this bank back in March. The worst of its…
Ulta Beauty (NASDAQ:ULTA) stock has been falling over the past year by over 30%. Recession fears have pushed down stocks selling discretionary…
Golar LNG Limited (NASDAQ:GLNG) Q2 2024 Earnings Conference Call August 15, 2024 8:00 AM ET Company Participants Karl Fredrik Staubo – CEOEduardo…
Vislink Technologies, Inc. (NASDAQ:VISL) Q2 2024 Earnings Conference Call August 14, 2024 8:30 AM ET Company Participants Mickey Miller – Chief Executive…
Deutsche Bank: Risk-Return Profile Not Attractive Enough Following Q2 Earnings (NYSE:DB)
By Press Room
5 Mins read
Deutsche Bank Aktiengesellschaft (NYSE:DB) has reported a muted performance in Q2 2024, impacted by legacy issues related to the Postbank acquisition in…